Concurrent Brain Subregion Microgliosis in an HLA-II Mouse Model of Group A Streptococcal Skin Infection

Suba Nookala1, Santhosh Mukundan1, Bryon Grove1

  • 1Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.

Microorganisms
|September 28, 2023
PubMed

Insights

Subcutaneous Group A Streptococcus (GAS) infection impacts the brain, causing intraneuronal bacteria and neuroinflammation. Treatment reduced skin GAS but not brain burden, indicating a persistent neuroimmune response.

Area of Science:

  • Neuroimmunology
  • Microbiology
  • Infectious Diseases

Background:

  • Group A Streptococcus (GAS) causes severe infections with potential neurological complications.
  • Understanding the skin-brain axis in GAS infections is crucial for public health.
  • Specific host factors, like HLA-DQ8, may influence neuroimmune responses.

Purpose of the Study:

  • To investigate the neuroimmune effects of subcutaneous GAS infection in HLA-DQ8 transgenic mice.
  • To examine the impact of clindamycin treatment on GAS burden and neuroinflammation.
  • To explore the skin-brain axis communication during GAS infection.

Main Methods:

  • Subcutaneous GAS infection in HLA-DQ8 mice, with groups receiving no treatment or clindamycin.
  • Monitoring of GAS burden in skin and brain (cortex, hippocampus).
  • Analysis of cytokine profiles, microglial marker Iba-1 expression, and bacterial presence in neural tissues.

Main Results:

  • Clindamycin treatment reduced skin GAS burden but not cortical or hippocampal GAS burden in males.
  • GAS bacteria were found within neuronal nuclei in the neocortex of treated and untreated infected mice.
  • Increased levels of IL-2, IL-13, IL-22, and IL-10 were observed in female mice post-treatment, despite no detectable GAS burden.
  • Elevated Iba-1 protein levels (microglia marker) were found in infected mice, with increased hippocampal immunoreactivity in treated males.

Conclusions:

  • Subcutaneous GAS infection can lead to intraneuronal bacterial presence and neuroinflammation in the brain.
  • The skin-brain axis is affected, characterized by microgliosis and altered cytokine profiles, even without bacteremia.
  • Treatment efficacy may differ between peripheral sites and the central nervous system, highlighting the complexity of GAS neuroinvasion.

Related Concept Videos